Cardinal Health warned Thursday that if President Donald Trump follows through with threatened tariffs next month, higher ...

President Donald Trump on Saturday signed executive orders imposing sweeping tariffs on the country’s three largest trading ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Fintel reports that on February 5, 2025, Jefferies upgraded their outlook for Cardinal Health (NYSE:CAH) from Hold to Buy.

Mizuho Securities analyst Steven Valiquette has reiterated their bullish stance on CAH stock, giving a Buy rating yesterday.Invest with ...

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...

Cardinal Health gets downgraded to a hold ... A key risk in this segment is that of regulatory and legal costs involving medical products and drugs. From its profile, what this firm is known ...

In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe ...

Bank of America Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health (CAH – Research Report) today. The company’s shares ...

distributing pharmaceuticals and medical products to over 60,000 locations daily. At the helm of technology and business services is Michelle Greene, Cardinal Health’s Chief Information Officer ...

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share ...